These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19725932)

  • 21. Uric acid and cardiovascular disease: A clinical review.
    Saito Y; Tanaka A; Node K; Kobayashi Y
    J Cardiol; 2021 Jul; 78(1):51-57. PubMed ID: 33388217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hyperuricemia, gout and high cardiovascular risk - how to manage them in clinical practice].
    Fomin VV; Morosova TE; Tsurko VV
    Ter Arkh; 2019 Dec; 91(12):75-83. PubMed ID: 32598593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of urate-lowering treatment on cardiovascular and renal disease: evidence from CARES, FAST, ALL-HEART, and FEATHER studies.
    Pontremoli R
    Curr Med Res Opin; 2017 Nov; 33(sup3):27-32. PubMed ID: 28952388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coexistent Hyperuricemia and Gout in Rheumatoid Arthritis: Associations With Comorbidities, Disease Activity, and Mortality.
    Chiou A; England BR; Sayles H; Thiele GM; Duryee MJ; Baker JF; Singh N; Cannon GW; Kerr GS; Reimold A; Gaffo A; Mikuls TR
    Arthritis Care Res (Hoboken); 2020 Jul; 72(7):950-958. PubMed ID: 31074584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hyperuricemia and the metabolic syndrome].
    Mitu F; Drăgan MV
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1001-5. PubMed ID: 20191866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [HYPERURICEMIA AND POTENTIAL RISK OF CARDIOVASCULAR AND RENAL DISEASES].
    Schils R; Krzesinski JM
    Rev Med Liege; 2016 May; 71(5):262-8. PubMed ID: 27337847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hyperuricemia - more than gout : Impact on cardiovascular risk and renal insufficiency].
    Sellin L; Kielstein JT; de Groot K
    Z Rheumatol; 2015 May; 74(4):322-8. PubMed ID: 25962453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
    Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of serum uric acid on blood-pressure lowering treatment.
    Grassi G
    Curr Med Res Opin; 2017 Nov; 33(sup3):15-19. PubMed ID: 28952389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comment on: Gout: an independent risk factor for all-cause and cardiovascular mortality.
    Mascitelli L; Pezzetta F; Goldstein MR
    Rheumatology (Oxford); 2010 Jul; 49(7):1421-2; author reply 1422. PubMed ID: 20427295
    [No Abstract]   [Full Text] [Related]  

  • 31. [Is hyperuricemia a cardiovascular risk factor?].
    Chizyński K; Rózycka M
    Wiad Lek; 2006; 59(5-6):364-7. PubMed ID: 17017483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease.
    Johnson RJ; Kivlighn SD; Kim YG; Suga S; Fogo AB
    Am J Kidney Dis; 1999 Feb; 33(2):225-34. PubMed ID: 10023633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperuricemia and cardiovascular risk.
    Grassi D; Desideri G; Di Giacomantonio AV; Di Giosia P; Ferri C
    High Blood Press Cardiovasc Prev; 2014 Dec; 21(4):235-42. PubMed ID: 24554489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy].
    Eliseev MS; Novikova AM
    Ter Arkh; 2019 May; 91(5):120-128. PubMed ID: 32598686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly.
    Franchi C; Salerno F; Conca A; Djade CD; Tettamanti M; Pasina L; Corrao S; Marengoni A; Marcucci M; Mannucci PM; Nobili A;
    Eur J Intern Med; 2014 Nov; 25(9):847-52. PubMed ID: 25439099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uric acid: friend or foe? Uric acid and cognitive function "Gout kills more wise men than simple".
    De Giorgi A; Fabbian F; Pala M; Tiseo R; Parisi C; Misurati E; Manfredini R
    Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):640-6. PubMed ID: 25753882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Contribution of the CoLaus study to decipher the determinants of serum uric acid].
    Bochud M; Vollenweider P; Waeber G
    Rev Med Suisse; 2011 Nov; 7(315):2142, 2144-5. PubMed ID: 22187784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies on association between nonalcoholic fatty liver disease and hyperuricemia: current status and future prospects].
    Li Y
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):89-91. PubMed ID: 26983473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug treatment of hyperuricemia to prevent cardiovascular outcomes: are we there yet?
    Gaffo AL; Saag KG
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):1-6. PubMed ID: 22204636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical implications of hyperuricemia.
    Sachs L; Batra KL; Zimmermann B
    Med Health R I; 2009 Nov; 92(11):353-5. PubMed ID: 19999892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.